1. General Principles (Foundations of Medicine)
	1.1. Biochemistry and molecular biology
		1.1.1. gene expression: DNA structure|| replication|| exchange|| and epigenetics
		1.1.2. gene expression: transcription
		1.1.3. gene expression: translation|| post-translational processing|| modifications|| and disposition of proteins||		degradation||protein/glycoprotein synthesis|| intra/extracellular sorting|| and processes/functions related to Golgi complex and rough endoplasmic reticulum
		1.1.4. structure and function of proteins and enzymes
		1.1.5. energy metabolism
	1.2. Biology of cells
		1.2.1. adaptive cell responses and cellular homeostasis
		1.2.2. intracellular accumulations
		1.2.3. mechanisms of injury and necrosis
		1.2.4. apoptosis
		1.2.5. mechanisms of dysregulation
			1.2.5.1. cell biology of cancer||		genetics of cancer
			1.2.5.2. general principles of invasion and metastasis||		cancer staging
		1.2.6. cell/tissue structure|| regulation|| and function||		cytoskeleton|| organelles|| glycolipids|| channels|| gap
		1.2.7. junctions|| extracellular matrix|| and receptors
2. Human development and genetics (Genetics and Neoplasia)
	2.1. principles of pedigree analysis
		2.1.1. inheritance patterns
		2.1.2. occurrence and recurrence risk determination
	2.2. population genetics: Hardy-Weinberg law|| founder effects|| mutation-selection equilibrium
	2.3. principles of gene therapy
	2.4. genetic testing and counseling
	2.5. genetic mechanisms
3. Biology of tissue response to disease (Inflammation and Immunity)
	3.1. acute inflammatory responses (patterns of response)
		3.1.1. acute inflammation and mediator systems
		3.1.2. vascular response to injury||		mediators
		3.1.3. principles of cell adherence and migration
		3.1.4. microbicidal mechanisms and tissue injury
		3.1.5. clinical manifestations
	3.2. chronic inflammatory responses
	3.3. reparative processes
		3.3.1. wound healing|| hemostasis|| and repair; thrombosis|| granulation tissue|| angiogenesis|| fibrosis|| scar/keloid formation
		3.3.2. regenerative processes
4. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
	4.1. progression through the life cycle||		birth through senescence (Medicine Across the Lifespan)
		4.1.1. cognitive|| language|| motor skills|| and social and interpersonal development
		4.1.2. sexual development
		4.1.3. influence of developmental stage on physician-patient interview
	4.2. psychological and social factors influencing patient behavior
		4.2.1. personality traits or coping style||		coping mechanisms
		4.2.2. psychodynamic and behavioral factors|| related past experience
		4.2.3. family and cultural factors||		socioeconomic status|| ethnicity|| and gender
		4.2.4. adaptive behavioral responses to stress and illness
		4.2.5. maladaptive behavioral responses to stress and illness
		4.2.6. interactions between the patient and the physician or the health care system
		4.2.7. patient adherence (general and adolescent)
	4.3. patient interviewing|| consultation|| and interactions with the family
		4.3.1. establishing and maintaining rapport
		4.3.2. data gathering
		4.3.3. approaches to patient education
		4.3.4. enticing patients to make lifestyle changes
		4.3.5. communicating bad news
		4.3.6. “difficult” interviews
		4.3.7. multicultural ethnic characteristics
	4.4. medical ethics|| jurisprudence|| and professional behavior
		4.4.1. consent and informed consent to treatment
		4.4.2. physician-patient relationships
		4.4.3. death and dying
		4.4.4. birth-related issues
		4.4.5. issues related to patient participation in research
		4.4.6. interactions with other health professionals||		impaired physician and patient safety
		4.4.7. sexuality and the profession; other “boundary” issues
		4.4.8. ethics of managed care
		4.4.9. organization and cost of health care delivery
5. Multisystem processes
	5.1. nutrition (GI/Nutrition)
		5.1.1. generation|| expenditure|| and storage of energy at the whole-body level
		5.1.2. assessment of nutritional status across the life span||		calories|| protein|| essential nutrients|| hypoalimentation
		5.1.3. functions of nutrients
		5.1.4. protein-calorie malnutrition
		5.1.5. vitamin deficiencies and/or toxicities			megaloblastic anemia
		5.1.6. mineral deficiencies and toxicities
	5.2. temperature regulation
	5.3. adaptation to environmental extremes (Integration and Consolidation)||		occupational exposures (Integration and Consolidation)
		5.3.1. physical and associated disorders			temperature|| radiation|| burns|| decreased atmospheric pressure|| high-altitude sickness|| increased water pressure)
		5.3.2. chemical			gases|| vapors|| smoke inhalation|| agricultural hazards|| organic solvents|| heavy metals|| principles of poisoning and therapy
	5.4. fluid|| electrolyte|| and acid-base balance disorders
6. inherited metabolic disorders||		disorders related to amino acids|| purines|| porphyrins|| carnitine|| fatty acids|| and carbohydrates
7. Pharmacodynamic and pharmacokinetic processes (Integration and Consolidation)
	7.1. general principles
		7.1.1. pharmacokinetics: absorption|| distribution|| metabolism|| excretion|| dosage intervals
		7.1.2. mechanisms of drug action|| structure-activity relationships			anticancer drugs)
		7.1.3. concentration- and dose-effect relationships|| types of agonists and antagonists and their actions
		7.1.4. individual factors altering pharmacokinetics and pharmacodynamics
		7.1.5. mechanisms of drug adverse effects|| overdosage|| toxicology
		7.1.6. mechanisms of drug interactions
		7.1.7. regulatory issues
		7.1.8. signal transduction||		structure/function of all components of signal transduction pathway such as receptors|| ligands
		7.1.9. cell cycle/cell cycle regulation
8. Microbial biology and infection
	8.1. microbial identification and classification||		principles|| microorganism identification|| and non-immunologic
	8.2. lab diagnosis
	8.3. bacteria
		8.3.1. structure
		8.3.2. processes|| replication|| and genetics
		8.3.3. oncogenesis
		8.3.4. antibacterial agents
	8.4. viruses
		8.4.1. structure
		8.4.2. processes|| replication|| and genetics
		8.4.3. oncogenesis
		8.4.4. antiviral agents
	8.5. fungi
		8.5.1. structure
		8.5.2. processes|| replication|| and genetics
		8.5.3. antifungal agents
	8.6. parasites
		8.6.1. structure
		8.6.2. processes|| replication|| and genetics
		8.6.3. antiparasitic agents
	8.7. prions
	8.8. epidemiology|| outbreaks|| and infection control
9. Quantitative methods (Foundations of Medicine)
	9.1. fundamental concepts of measurement
		9.1.1. scales of measurement
		9.1.2. distribution|| central tendency|| variability|| probability
		9.1.3. disease prevalence and incidence
		9.1.4. disease outcomes
		9.1.5. associations
		9.1.6. health impact
		9.1.7. sensitivity|| specificity|| predictive values
	9.2. fundamental concepts of study design
		9.2.1. types of experimental studies
		9.2.2. types of observational studies
		9.2.3. sampling and sample size
		9.2.4. subject selection and exposure allocation
		9.2.5. outcome assessment
		9.2.6. internal and external validity
	9.3. fundamental concepts of hypothesis testing and statistical inference
		9.3.1. confidence intervals
		9.3.2. statistical significance and Type I error
		9.3.3. statistical power and Type II error
10. Hematopoietic and Lymphoreticular Systems (Blood and Lymphoid)
	10.1. Normal processes
		10.1.1. embryonic development|| fetal maturation|| and perinatal changes
		10.1.2. organ structure and function
		10.1.3. cell/tissue structure and function
			10.1.3.1. production and function of erythrocytes|| hemoglobin|| O2 and CO2 transport|| transport proteins
			10.1.3.2. production and function of platelets
			10.1.3.3. production and function of coagulation and fibrinolytic factors
		10.1.4. repair|| regeneration|| and changes associated with stage of life
	10.2. Abnormal processes
		10.2.1. infectious|| inflammatory|| and immunologic disorders
			10.2.1.1. infections of the blood|| reticuloendothelial system|| and endothelial cells
			10.2.1.2. autoimmunity and autoimmune diseases
			10.2.1.3. anemia of chronic disease
			10.2.1.4. non-immunologically mediated transfusion complications|| transplant rejection
		10.2.2. traumatic and mechanical injury
		10.2.3. neoplastic disorders			lymphoma|| leukemia|| multiple myeloma|| dysproteinemias|| amyloidosis
		10.2.4. metabolic and regulatory disorders||		acquired
			10.2.4.1. nutritional anemias
			10.2.4.2. cythemia
			10.2.4.3. hemorrhagic and hemostatic disorders
			10.2.4.4. bleeding secondary to platelet disorders and disorders of primary hemostasis
		10.2.5. vascular and endothelial disorders
		10.2.6. systemic disorders affecting the hematopoietic and lymphoreticular system
		10.2.7. idiopathic disorders
		10.2.8. degenerative disorders
		10.2.9. drug-induced adverse effects of the hematopoietic and lymphoreticular systems
		10.2.10. congenital and genetic disorders affecting the hematopoietic and lymphoreticular systems
	10.3. Principles of therapeutics
		10.3.1. mechanisms of action and use of drugs for treatment of disorders of the hematopoietic system
			10.3.1.1. blood and blood products
			10.3.1.2. treatment of anemia|| drugs stimulating erythrocyte production
			10.3.1.3. drugs stimulating leukocyte production
			10.3.1.4. anti-coagulants|| thrombolytic drugs
			10.3.1.5. anti-platelet drugs
			10.3.1.6. anti-microbials and anti-parasitics
			10.3.1.7. anti-neoplastic and immunosuppressive drugs in the clinical context of disease
			10.3.1.8. other therapeutic modalities
		10.3.2. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			10.3.2.1. emotional and behavioral factors
			10.3.2.2. influence on person|| family|| and society
			10.3.2.3. occupational and other environmental risk factors
			10.3.2.4. gender and ethnic factors
11. Central and Peripheral Nervous Systems (Brain and Behavior)
	11.1. Normal processes
		11.1.1. embryonic development|| fetal maturation|| and perinatal changes||		neural tube derivatives||
		11.1.2. cerebral ventricles|| neural crest derivatives
		11.1.3. organ structure and function
			11.1.3.1. spinal cord||		gross anatomy|| blood supply|| and spinal reflexes
			11.1.3.2. brain stem
			11.1.3.3. brain||		gross anatomy and blood supply; cognition|| language|| memory; hypothalamic function; limbic system and emotional behavior; circadian rhythms and sleep; control of eye movement
			11.1.3.4. sensory systems||		proprioception|| pain|| vision|| hearing|| balance|| taste|| and olfaction
			11.1.3.5. motor systems||		brain and spinal cord|| basal ganglia|| and cerebellum
			11.1.3.6. autonomic nervous system
			11.1.3.7. peripheral nerve
		11.1.4. cell/tissue structure and function
			11.1.4.1. axonal transport
			11.1.4.2. excitable properties of neurons|| axons|| and dendrites||		channels
			11.1.4.3. synthesis|| storage|| release|| reuptake|| and degradation of neurotransmitters and neuromodulators
			11.1.4.4. pre- and postsynaptic receptor interactions|| trophic and growth factors
			11.1.4.5. brain metabolism
			11.1.4.6. glia|| myelin
			11.1.4.7. brain homeostasis: blood-brain barrier; cerebrospinal fluid formation and flow; choroid plexus
		11.1.5. repair|| regeneration|| and changes associated with stage of life||		definition of brain death
		11.1.6. Abnormal processes
			11.1.6.1. infectious|| inflammatory|| and immunologic disorders			demyelinating disorders|| myasthenia gravis and muscle channelopathies|| and disorders of the eye and ear)
			11.1.6.2. traumatic and mechanical disorders
			11.1.6.3. neoplastic disorders||		primary and metastatic
			11.1.6.4. metabolic and regulatory disorders
			11.1.6.5. vascular disorders
			11.1.6.6. systemic disorders affecting the nervous system
			11.1.6.7. idiopathic disorders affecting the nervous system
			11.1.6.8. congenital and genetic disorders||		metabolic
			11.1.6.9. degenerative disorders
			11.1.6.10. paroxysmal disorders
			11.1.6.11. disorders of special senses
			11.1.6.12. psychopathologic disorders|| processes|| and their evaluation
				11.1.6.12.1. early-onset disorders
				11.1.6.12.2. disorders related to substance use
				11.1.6.12.3. schizophrenia and other psychotic disorders
				11.1.6.12.4. mood disorders
				11.1.6.12.5. anxiety disorders
				11.1.6.12.6. somatoform disorders
				11.1.6.12.7. personality disorders
				11.1.6.12.8. physical and sexual abuse of children|| adults|| and elders
				11.1.6.12.9. other disorders
		11.1.7. drug-induced adverse effects on the central and peripheral nervous system
		11.1.8. neurologic pain syndromes
		11.1.9. Principles of therapeutics
		11.1.10. mechanisms of action and use of drugs for treatment of disorders of the nervous system
			11.1.10.1. anesthetics
			11.1.10.2. hypnotic sedatives
			11.1.10.3. psychopharmacologic agents
			11.1.10.4. anticonvulsants
			11.1.10.5. analgesics
			11.1.10.6. stimulants|| amphetamines
			11.1.10.7. anti-parkinsonian drugs and drugs for dementia|| Alzheimer type; multiple sclerosis; and restless legs syndrome
			11.1.10.8. skeletal muscle relaxants|| botulinum toxin
			11.1.10.9. neuromuscular junction agonists and antagonists
			11.1.10.10. antiglaucoma drugs
			11.1.10.11. drugs used to decrease intracranial pressure
			11.1.10.12. antimigraine agents
			11.1.10.13. drugs affecting the autonomic nervous system||		all general autonomic pharmacology
			11.1.10.14. antimicrobials|| antineoplastic drugs|| and antiparasitics
			11.1.10.15. drugs used to treat cerebrovascular disorders
			11.1.10.16. treatment for substance abuse disorders
			11.1.10.17. other therapeutic modalities
		11.1.11. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial||
			11.1.11.1. cultural|| occupational|| and environmental
			11.1.11.2. emotional and behavioral factors
			11.1.11.3. influence on person|| family|| and society
			11.1.11.4. occupational and other environmental risk factors
			11.1.11.5. gender and ethnic factors
12. Skin and Related Connective Tissue (Musculoskeletal|| Skin and Soft Tissue)
	12.1. Normal processes
		12.1.1. embryonic development|| fetal maturation|| and perinatal changes
		12.1.2. organ structure and function
		12.1.3. cell/tissue structure and function||		barrier functions|| thermal regulation|| eccrine function
		12.1.4. repair|| regeneration|| and changes associated with stage of life or ethnicity
		12.1.5. skin defense mechanisms and normal flora
	12.2. Abnormal processes
		12.2.1. infectious|| inflammatory|| and immunologic disorders
			12.2.1.1. bacterial infections
			12.2.1.2. viral infections
			12.2.1.3. fungal infections||		mycoses|| dermatophytosis
			12.2.1.4. parasitic infections|| ectoparasitic infestations|| and mycobacterial infections
			12.2.1.5. immune and autoimmune disorders
		12.2.2. traumatic and mechanical disorders
			12.2.2.1. thermal injury
			12.2.2.2. decubitus ulcers
			12.2.2.3. effects of ultraviolet light and radiation
		12.2.3. neoplastic disorders
			12.2.3.1. keratinocytes
			12.2.3.2. melanocytes
			12.2.3.3. vascular neoplasms
			12.2.3.4. other
		12.2.4. metabolic|| regulatory|| and structural disorders
		12.2.5. vascular disorders
		12.2.6. systemic disorders affecting the skin
		12.2.7. idiopathic disorders
		12.2.8. degenerative disorders
		12.2.9. drug-induced adverse effects on the skin and related connective tissue
		12.2.10. congenital and genetic disorders affecting the skin and related connective tissue
	12.3. Principles of therapeutics
		12.3.1. mechanisms of action and use of drugs for treatment of disorders of the skin and connective tissue
			12.3.1.1. anti-inflammatory agents
			12.3.1.2. emollients
			12.3.1.3. sunscreen
			12.3.1.4. retinoids
			12.3.1.5. antimicrobial and antiparasitic agents
			12.3.1.6. cytotoxic and immunologic therapy and antineoplastic drugs
			12.3.1.7. other therapeutic modalities
	12.4. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
		12.4.1. emotional and behavioral factors
		12.4.2. influence on person|| family|| and society
		12.4.3. occupational and other environmental risk factors
		12.4.4. gender and ethnic factors
13. Musculoskeletal System (Musculoskeletal|| Skin and Soft Tissue)
	13.1. Normal processes
		13.1.1. embryonic development|| fetal maturation|| and perinatal changes
		13.1.2. organ structure and function
		13.1.3. cell/tissue structure and function
			13.1.3.1. biology of bones|| joints|| tendons|| skeletal muscle
			13.1.3.2. exercise and physical conditioning
	13.2. repair|| regeneration|| and changes associated with stage of life
	13.3. Abnormal processes
		13.3.1. infectious|| inflammatory|| and immunologic disorders
		13.3.2. traumatic and mechanical disorders			fractures|| sprains|| strains|| dislocations|| joint injuries|| repetitive
		13.3.3. motion injuries|| and impingement syndromes)
		13.3.4. neoplastic disorders
		13.3.5. metabolic|| regulatory|| and structural disorders			osteomalacia||
		13.3.6. osteoporosis|| osteodystrophy|| gout|| and pseudogout)
		13.3.7. vascular disorders
		13.3.8. systemic disorders affecting the musculoskeletal system
		13.3.9. idiopathic disorders
		13.3.10. degenerative disorders
		13.3.11. drug-induced adverse effects on the musculoskeletal system
		13.3.12. congenital and genetic disorders affecting the musculoskeletal system
	13.4. Principles of therapeutics
		13.4.1. mechanisms of action and use of drugs for treatment of disorders of the musculoskeletal system
			13.4.1.1. non-steroidal anti-inflammatory drugs and analgesics
			13.4.1.2. muscle relaxants
			13.4.1.3. anti-gout therapy
			13.4.1.4. immunosuppressive and antineoplastic drugs
			13.4.1.5. drugs affecting bone mineralization
			13.4.1.6. anti-microbial and anti-parasitic agents
			13.4.1.7. other therapeutic modalities
		13.4.2. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			13.4.2.1. emotional and behavioral factors
			13.4.2.2. influence on person|| family|| and society
			13.4.2.3. occupational and other environmental risk factors
			13.4.2.4. gender and ethnic factors
14. Respiratory System (Cardiopulmonary)
	14.1. Normal processes
		14.1.1. embryonic development|| fetal maturation|| and perinatal changes
		14.1.2. organ structure and function
			14.1.2.1. airways||		mechanics and regulation of breathing
			14.1.2.2. lung parenchyma||		ventilation|| perfusion|| gas exchange
			14.1.2.3. pleura
			14.1.2.4. nasopharynx and sinuses
		14.1.3. cell/tissue structure and function||		surfactant formation|| alveolar structure
	14.2. repair|| regeneration|| and changes associated with stage of life
	14.3. pulmonary defense mechanisms and normal flora
	14.4. Abnormal processes
		14.4.1. infectious|| inflammatory|| and immunologic disorders
			14.4.1.1. infectious diseases
			14.4.1.2. infectious diseases of the upper respiratory tract
			14.4.1.3. pyogenic infectious diseases of the lower respiratory tract and pleura||		viral infections||complications
			14.4.1.4. other infectious diseases of the lower respiratory tract
			14.4.1.5. immunologic disorders
			14.4.1.6. allergic and hypersensitivity disorders
			14.4.1.7. autoimmune disorders
			14.4.1.8. inflammatory disorders
			14.4.1.9. pneumoconioses
			14.4.1.10. acute and chronic alveolar injury
			14.4.1.11. chronic obstructive pulmonary disease
			14.4.1.12. restrictive pulmonary disease
			14.4.1.13. traumatic and mechanical disorders
	14.5. neoplastic disorders			upper airway|| lower airway and lung parenchyma|| pleura|| and metastatic tumors)
	14.6. metabolic|| regulatory|| and structural disorders
	14.7. vascular and circulatory disorders			thromboembolic disease|| pulmonary hypertension|| pulmonary edema|| and pleural effusion)
	14.8. systemic disorders affecting the respiratory system
	14.9. idiopathic disorders
	14.10. degenerative disorders
	14.11. drug-induced adverse effects on the respiratory system
	14.12. congenital and genetic disorders affecting the respiratory system
	14.13. Principles of therapeutics
		14.13.1. mechanisms of action and use of drugs for treatment of disorders of the respiratory system
			14.13.1.1. decongestants|| cough suppressants|| expectorants|| mucolytics
			14.13.1.2. bronchodilator drugs
			14.13.1.3. anti-inflammatory and cytotoxic drugs
			14.13.1.4. antimicrobial agents and antiparasitic agents
			14.13.1.5. antineoplastic agents
			14.13.1.6. pulmonary vasodilators
			14.13.1.7. other therapeutic modalities
		14.13.2. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			14.13.2.1. emotional and behavioral factors
			14.13.2.2. influence on person|| family|| and society
			14.13.2.3. occupational and other environmental risk factors
			14.13.2.4. gender and ethnic factors
15. Cardiovascular System (Cardiopulmonary)
	15.1. Normal processes
		15.1.1. embryonic development|| fetal maturation|| and perinatal changes
		15.1.2. organ structure and function
			15.1.2.1. chambers|| valves
			15.1.2.2. cardiac cycle|| mechanics|| heart sounds|| cardiac conduction
			15.1.2.3. hemodynamics||		systemic|| pulmonary|| coronary|| and blood volume
			15.1.2.4. circulation in specific vascular beds
			15.1.2.5. cell/tissue structure and function
			15.1.2.6. heart muscle|| metabolism|| oxygen consumption|| biochemistry|| and secretory function
			15.1.2.7. endothelium and secretory function|| vascular smooth muscle|| microcirculation|| and lymph flow			mechanisms of atherosclerosis
			15.1.2.8. neural and hormonal regulation of the heart|| blood vessels|| and blood volume||		responses to
			15.1.2.9. change in posture|| exercise|| and tissue metabolism
			15.1.2.10. repair|| regeneration|| and changes associated with stage of life
	15.2. Abnormal processes
		15.2.1. infectious|| inflammatory|| and immunologic disorders
		15.2.2. traumatic and mechanical disorders
		15.2.3. neoplastic disorders
		15.2.4. metabolic and regulatory disorders		dysrhythmias|| systolic and diastolic dysfunction||low- and    high-output heart failure||cor pulmonale||systemic hypertension||ischemic heart disease||myocardial infarction||systemic hypotension and shock||and dyslipidemias)
		15.2.7. vascular disorders
		15.2.8. systemic diseases affecting the cardiovascular system
		15.2.9. congenital and genetic disorders of the heart and central vessels
		15.2.10. idiopathic disorders
		15.2.11. drug-induced adverse effects on the cardiovascular system
		15.2.12. degenerative disorders
	15.3. Principles of therapeutics
		15.3.1. mechanisms of action|| use|| and adverse effects of drugs for treatment of disorders of the cardiovascular system
			15.3.1.1. coronary and peripheral vasodilators
			15.3.1.2. antiarrhythmic drugs
			15.3.1.3. antihypertensive drugs
			15.3.1.4. measures used to combat hypotension and shock
			15.3.1.5. drugs affecting cholesterol and lipid metabolism
			15.3.1.6. drugs affecting blood coagulation|| thrombolytic agents|| and antiplatelet agents
			15.3.1.7. inotropic agents and treatment of heart failure
			15.3.1.8. immunosuppressive|| antimicrobial|| antineoplastic|| and antiparasitic drugs
			15.3.1.9. drugs to treat peripheral arterial disease
			15.3.1.10. other pharmacotherapy
			15.3.1.11. other therapeutic modalities
		15.3.2. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			15.3.2.1. emotional and behavioral factors
			15.3.2.2. influence on person|| family|| and society
			15.3.2.3. occupational and other environmental risk factors
			15.3.2.4. gender and ethnic factors
16. Gastrointestinal System (GI-Nutrition)
	16.1. Normal processes
		16.1.1. embryonic development|| fetal maturation|| and perinatal changes
		16.1.2. organ structure and function||		alimentary canal|| liver and biliary system|| salivary glands and exocrine pancreas|| motility|| and digestion and absorption
		16.1.3. cell/tissue structure and function
			16.1.3.1. endocrine and neural regulatory functions||		GI hormones
			16.1.3.2. salivary|| gastrointestinal|| pancreatic|| hepatic secretory products||		enzymes|| proteins|| bile salts|| and processes
			16.1.3.3. synthetic and metabolic functions of hepatocytes
		16.1.4. repair|| regeneration|| and changes associated with stage of life
		16.1.5. gastrointestinal defense mechanisms and normal flora
	16.2. Abnormal processes
		16.2.1. infectious|| inflammatory|| and immunologic disorders
		16.2.2. traumatic and mechanical disorders
			16.2.2.1. malocclusion
			16.2.2.2. hiatal hernia
			16.2.2.3. obstruction
			16.2.2.4. perforation of hollow viscus and blunt trauma
			16.2.2.5. inguinal|| femoral|| and abdominal wall hernias
			16.2.2.6. esophageal|| intestinal|| and colonic diverticula
		16.2.3. neoplastic disorders||		benign and malignant
		16.2.4. metabolic and regulatory disorders			motility disorders|| malabsorption|| hepatic failure|| cholelithiasis|| nutritional disorders)
		16.2.5. vascular disorders			portal hypertension|| esophageal varices|| hemorrhoids|| anal fissure|| ischemia|| angiodysplasia|| thromboses|| vasculitis
		16.2.6. systemic disorders affecting the gastrointestinal system
		16.2.7. idiopathic disorders
		16.2.8. degenerative disorders
		16.2.9. drug-induced adverse effects on the gastrointestinal system
		16.2.10. congenital and genetic disorders affecting the gastrointestinal system
	16.3. Principles of therapeutics
		16.3.1. mechanisms of action and use of drugs for treatment of disorders of the gastrointestinal system
			16.3.1.1. treatment and prophylaxis of peptic ulcer disease and gastroesophageal reflux
			16.3.1.2. drugs to alter gastrointestinal motility
			16.3.1.3. fluid replacement
			16.3.1.4. pancreatic replacement therapy and treatment of pancreatitis
			16.3.1.5. drugs for treatment of hepatic failure and biliary disease
			16.3.1.6. anti-inflammatory|| immunosuppressive|| antineoplastic|| antimicrobial|| and antiparasitic drugs
			16.3.1.7. other therapeutic modalities
		16.3.2. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			16.3.2.1. emotional and behavioral factors
			16.3.2.2. influence on person|| family|| and society
			16.3.2.3. occupational and other environmental risk factors
			16.3.2.4. gender and ethnic factors
17. Renal/Urinary System (Renal-Endocrine)
	17.1. Normal processes
		17.1.1. embryonic development|| fetal maturation|| and perinatal changes
		17.1.2. organ structure and function
			17.1.2.1. kidneys|| ureters|| bladder|| urethra
			17.1.2.2. glomerular filtration and hemodynamics
			17.1.2.3. tubular reabsorption and secretion||		transport processes and proteins
			17.1.2.4. urinary concentration and dilution
			17.1.2.5. renal mechanisms in acid-base balance
			17.1.2.6. renal mechanisms in body fluid homeostasis
			17.1.2.7. micturition
		17.1.3. cell/tissue structure and function||		renal metabolism and oxygen consumption|| hormones produced by or acting on the kidney
		17.1.4. repair|| regeneration|| and changes associated with stage of life
	17.2. Abnormal processes
		17.2.1. infectious|| inflammatory|| and immunologic disorders
			17.2.1.1. infectious disorders
			17.2.1.2. upper urinary tract
			17.2.1.3. lower urinary tract
			17.2.1.4. inflammatory and immunologic disorders
			17.2.1.5. glomerular disorders
			17.2.1.6. tubular interstitial disease
		17.2.2. traumatic and mechanical disorders
		17.2.3. neoplastic disorders||		primary and metastases
		17.2.4. metabolic and regulatory disorders
			17.2.4.1. renal failure|| acute and chronic
			17.2.4.2. tubular and collecting duct disorders
			17.2.4.3. renal calculi
		17.2.5. vascular disorders
		17.2.6. systemic diseases affecting the renal system
		17.2.7. idiopathic disorders
		17.2.8. degenerative disorders
		17.2.9. drug-induced adverse effects on the renal/urinary system
		17.2.10. congenital and genetic disorders affecting the renal/urinary system
	17.3. Principles of therapeutics
		17.3.1. mechanisms of action and use of drugs for treatment of disorders of the renal and urinary system
			17.3.1.1. diuretics|| antidiuretic drugs
			17.3.1.2. drugs and fluids used to treat volume|| electrolyte|| and acid-base disorders
			17.3.1.3. drugs used to enhance renal perfusion
			17.3.1.4. anti-inflammatory|| antimicrobial|| immunosuppressive|| antineoplastic|| and antiparasitic drugs
			17.3.1.5. drugs used to treat lower urinary tract system
		17.3.2. other therapeutic modalities
		17.3.3. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial||
			17.3.3.1. cultural|| occupational|| and environmental
			17.3.3.2. emotional and behavioral factors
			17.3.3.3. influence on person|| family|| and society
			17.3.3.4. occupational and other environmental risk factors
			17.3.3.5. gender and ethnic factors
18. Reproductive System (Sexuality and Reproductive Medicine)
	18.1. Normal processes
		18.1.1. embryonic development|| fetal maturation|| and perinatal changes||		gametogenesis
		18.1.2. organ structure and function
			18.1.2.1. female structure||		breast
			18.1.2.2. female function
			18.1.2.3. male structure
			18.1.2.4. male function
			18.1.2.5. intercourse|| orgasm
			18.1.2.6. pregnancy||		ovulation|| fertilization|| implantation|| labor and delivery|| the puerperium|| lactation|| gestational uterus|| placenta
		18.1.3. cell/tissue structure and function||		hypothalamic-pituitary-gonadal axis|| sex steroids|| and gestational hormones
		18.1.4. reproductive system defense mechanisms and normal flora
	18.2. Abnormal processes
		18.2.1. infectious|| inflammatory|| and immunologic disorders (female and male)
		18.2.2. traumatic and mechanical disorders (female and male)
		18.2.3. neoplastic disorders			female reproductive|| male reproductive|| breast [including fibrocystic changes]|| trophoblastic disease
		18.2.4. metabolic and regulatory processes (female and male)
		18.2.5. prenatal and perinatal counseling and screening
		18.2.6. systemic disorders affecting reproductive function
	18.3. disorders relating to pregnancy|| the puerperium|| and the postpartum period
		18.3.1. obstetric problems
		18.3.2. complications affecting other organ systems
		18.3.3. disorders associated with the puerperium
		18.3.4. antepartum|| intrapartum|| postpartum disorders of the fetus
	18.4. idiopathic disorders
	18.5. drug-induced adverse effects on the reproductive system
	18.6. degenerative disorders
	18.7. congenital and genetic disorders affecting the reproductive system
	18.8. Principles of therapeutics
		18.8.1. mechanisms of action and use of drugs for treatment of disorders of the reproductive system and management of normal reproductive function
			18.8.1.1. female reproductive tract
			18.8.1.2. fertility drugs
			18.8.1.3. oral contraception|| other methods of contraception
			18.8.1.4. estrogen|| progesterone replacement|| treatment of menopause
			18.8.1.5. stimulants and inhibitors of labor
			18.8.1.6. estrogen and progesterone antagonists
			18.8.1.7. stimulators and inhibitors of lactation
			18.8.1.8. male reproductive tract
			18.8.1.9. fertility drugs
			18.8.1.10. androgen replacement and antagonists
			18.8.1.11. gonadotropin-releasing hormone and gonadotropin replacement||		all gonadotropin-releasing hormone antagonists
			18.8.1.12. abortifacients
			18.8.1.13. antimicrobial and antiparasitic agents
			18.8.1.14. antineoplastics
			18.8.1.15. restoration of potency
		18.8.2. other therapeutic modalities affecting the reproductive system
		18.8.3. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			18.8.3.1. emotional and behavioral factors
			18.8.3.2. influence on person|| family|| and society
			18.8.3.3. occupational and other environmental risk factors
			18.8.3.4. family planning and pregnancy
			18.8.3.5. gender identity|| sexual orientation|| sexuality|| libido
			18.8.3.6. effects of traumatic stress syndrome|| violence|| rape|| child abuse
19. Endocrine System (Renal-Endocrine)
	19.1. Normal processes
		19.1.1. embryonic development|| fetal maturation|| and perinatal changes
		19.1.2. organ structure and function
			19.1.2.1. hypothalamus|| posterior and anterior pituitary gland
			19.1.2.2. thyroid gland
			19.1.2.3. parathyroid glands
			19.1.2.4. adrenal cortex|| adrenal medulla
			19.1.2.5. pancreatic islets
			19.1.2.6. ovary and testis
			19.1.2.7. adipose tissue
		19.1.3. cell/tissue structure and function||		hormone synthesis|| secretion|| action|| and metabolism
			19.1.3.1. peptide hormones
			19.1.3.2. steroid hormones||		vitamin D
			19.1.3.3. thyroid hormones
			19.1.3.4. catecholamine hormones
			19.1.3.5. renin-angiotensin system
		19.1.4. repair|| regeneration|| and changes associated with stage of life
	19.2. Abnormal processes
		19.2.1. infectious|| inflammatory|| and immunologic disorders
		19.2.2. traumatic and mechanical disorders
		19.2.3. neoplastic disorders			pituitary|| thyroid|| parathyroid|| adrenal cortex|| pancreatic islets|| neural crest|| pheochromocytoma)
		19.2.4. metabolic and regulatory processes			diabetes mellitus|| pituitary|| hypothalamus|| thyroid||
		19.2.5. parathyroid|| pancreatic islet disorders|| adrenal disorders)
		19.2.6. vascular disorders
		19.2.7. systemic disorders affecting the endocrine system
		19.2.8. idiopathic disorders
		19.2.9. degenerative disorders
		19.2.10. drug-induced adverse effects on the endocrine system
		19.2.11. congenital and genetic disorders affecting the endocrine system
	19.3. Principles of therapeutics
		19.3.1. mechanisms of action and use of drugs for treatment of disorders of the endocrine system
			19.3.1.1. hormones and hormone analogs
			19.3.1.2. stimulators of hormone production
			19.3.1.3. inhibitors of hormone production
			19.3.1.4. hormone antagonists
			19.3.1.5. potentiators of hormone action
			19.3.1.6. antiobesity agents
			19.3.1.7. nonhormonal therapy for endocrine disorders
			19.3.1.8. other treatment for diabetes
		19.3.2. other therapeutic modalities
		19.3.3. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			19.3.3.1. emotional and behavioral factors
			19.3.3.2. influence on person|| family|| and society
			19.3.3.3. occupational and other environmental risk factors
			19.3.3.4. gender and ethnic factors
20. Immune System (Inflammation and Immunity)
	20.1. Normal processes
		20.1.1. development of cells of the adaptive immune response||		positive and negative selection during
		20.1.2. immune development
		20.1.3. structure|| production|| and function
			20.1.3.1. granulocytes|| natural killer cells|| macrophages|| mast cells|| dendritic cells|| cell receptors
			20.1.3.2. T lymphocytes||		T-lymphocyte receptors|| accessory molecules|| cell activation and proliferation||
			20.1.3.3. cytotoxic T lymphocytes|| and memory T lymphocytes
			20.1.3.4. B lymphocytes and plasma cells||		B-lymphocyte receptors|| immunoglobulins|| cell activation and proliferation|| including development of antibodies and memory B lymphocytes
			20.1.3.5. structure and function of lymph nodes|| host defense mechanisms|| host barriers to infection|| mucosal immunity
		20.1.4. immunogenetics
		20.1.5. Rh and ABO antigens||		genetics
		20.1.6. cellular basis of the immune response and immunologic mediators
		20.1.7. antigen processing and presentation in the context of MHC I and MHC II molecules||		distribution of MHC I and MHC II on different cells|| mechanism of MHC I and MHC II deficiencies|| and the genetics of MHC
		20.1.8. regulation of the adaptive immune response
		20.1.9. activation|| function|| and molecular biology of complement
		20.1.10. function and molecular biology of cytokines
		20.1.11. basis of immunologic diagnosis
	20.2. Abnormal processes
		20.2.1. disorders with alterations in immunologic function
			20.2.1.1. abnormalities in adaptive immune responses
			20.2.1.2. deficiencies of phagocytic cells and natural killer cells
			20.2.1.3. complement deficiency
			20.2.1.4. HIV infection/AIDS
			20.2.1.5. Non-HIV infections of lymphocytes
			20.2.1.6. systemic diseases of immunologic function
			20.2.1.7. systemic disorders affecting the immune system and the effect of age on the function of components of the immune system
		20.2.2. immunologically mediated disorders
			20.2.2.1. type I|| type II|| type III hypersensitivity
			20.2.2.2. type IV hypersensitivity
			20.2.2.3. transplantation risks and rejection||		transfusion reactions
			20.2.2.4. isoimmunization|| hemolytic disease of the newborn
		20.2.3. drug-induced adverse effects on the immune system			Jarisch-Herxheimer reaction
	20.3. Principles of therapeutics
		20.3.1. mechanisms of action and use of drugs that specifically affect immune function
			20.3.1.1. vaccines (active and passive)
			20.3.1.2. antiretrovirals
			20.3.1.3. immunomodulating and antineoplastic drugs
			20.3.1.4. biologics			monoclonal and polyclonal antibodies
		20.3.2. other therapeutic modalities
		20.3.3. Gender|| ethnic|| and behavioral considerations affecting disease treatment and prevention||		psychosocial|| cultural|| occupational|| and environmental
			20.3.3.1. emotional and behavioral factors
			20.3.3.2. influence on person|| family|| and society
			20.3.3.3. occupational and other environmental risk factors
			20.3.3.4. gender and ethnic factors
